Fingerprint
Dive into the research topics of 'Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): A multicentre, open-label, randomised phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically